Celldex Therapeutics buy Barclays PLC
Start price
08.05.26
/
50%
€28.82
Target price
08.05.27
€40.93
Performance (%)
19.95%
Price
21.08.26
?
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 19.95%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -8.164% | -8.164% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Barclays PLC from $45.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€36.10
07.08.26
07.08.26
€45.99
07.08.27
07.08.27
-4.24%
21.08.26
21.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.16
20.04.26
20.04.26
€38.28
20.04.27
20.04.27
18.55%
21.08.26
21.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
54.50%
21.08.26
21.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
61.92%
21.08.26
21.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
49.01%
21.08.26
21.08.26